The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Celgene
Comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in metastatic pancreatic cancer: A nationwide chart review in the United States.
 
Sunnie S. Kim
No Relationships to Disclose
 
James Signorovitch
No Relationships to Disclose
 
Hongbo Yang
Consulting or Advisory Role - Celgene
 
Oscar Patterson-Lomba
Consulting or Advisory Role - Celgene
 
Cheryl Xiang
Consulting or Advisory Role - Celgene
 
Brian Ung
Employment - Blue Peak Advisors
Travel, Accommodations, Expenses - Celgene
Other Relationship - Post doc fellow for industry
 
Monika Parisi
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
John Marshall
Honoraria - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bayer/Onyx; Genentech/Roche
Research Funding - Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); MedImmune (Inst); Pfizer (Inst)